# Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety

> **NCT01551303** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 47 (actual)

## Conditions studied

- Social Intelligence

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01551303
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551303, "Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01551303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*